Insider Trading activities of Scynexis Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Scynexis Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Scynexis Inc since year 2005. Table 2 shows the detailed insider transactions of Scynexis Inc since 2005. The reporting company's ticker symbol is SCYX. The reporting company's CIK number is 1178253.
The total value of stock buying since 2005 is $12,096,020.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Scynexis Inc (SCYX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 10,000 $22,300 0 $0 0 $0
2017-08 25,000 $40,848 0 $0 0 $0
2017-06 20,000 $35,000 0 $0 0 $0
2017-05 40,000 $67,750 0 $0 0 $0
2016-12 29,000 $95,500 0 $0 0 $0
2016-09 40,000 $117,600 0 $0 0 $0
2016-06 211,950 $500,408 0 $0 0 $0
2016-05 29,471 $96,246 0 $0 0 $0
2015-11 22,733 $154,434 0 $0 0 $0
2015-09 3,000 $21,000 0 $0 0 $0
2015-08 77,267 $564,934 0 $0 0 $0
2014-05 1,038,000 $10,380,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Scynexis Inc insiders (SCYX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-22 Taglietti Marco (Chief Executive Officer) Buy 10,000 2.23 22,300
2017-08-23 Taglietti Marco (Chief Executive Officer) Buy 4,993 1.85 9,237
2017-08-22 Taglietti Marco (Chief Executive Officer) Buy 7 1.61 11
2017-08-15 Taglietti Marco (Chief Executive Officer) Buy 10,000 1.61 16,100
2017-08-11 Angulo Gonzalez David (Chief Medical Officer) Buy 10,000 1.55 15,500
2017-06-21 Hastings David C Buy 20,000 1.75 35,000
2017-05-12 Angulo Gonzalez David (Chief Medical Officer) Buy 15,000 1.70 25,500
2017-05-12 Taglietti Marco (Chief Executive Officer) Buy 25,000 1.69 42,250
2016-12-21 Taglietti Marco (Chief Executive Officer) Buy 25,000 3.30 82,500
2016-12-16 Angulo Gonzalez David (Chief Medical Officer) Buy 4,000 3.25 13,000
2016-09-15 Machado Patrick Buy 40,000 2.94 117,600
2016-06-30 Angulo Gonzalez David (Chief Medical Officer) Buy 32,150 2.23 71,694
2016-06-29 Angulo Gonzalez David (Chief Medical Officer) Buy 4,800 2.18 10,464
2016-06-24 Francois Eric (Chief Financial Officer) Buy 15,000 2.39 35,850
2016-06-24 Taglietti Marco (Chief Executive Officer) Buy 100,000 2.39 239,000
2016-06-24 Machado Clarence Patrick Buy 20,000 2.39 47,800
2016-06-24 Macdonald Guy Buy 40,000 2.39 95,600
2016-05-25 Taglietti Marco (Chief Executive Officer) Buy 6,000 3.23 19,545
2016-05-25 Hanham Ann Buy 4,225 3.64 15,379
2016-05-24 Taglietti Marco (Chief Executive Officer) Buy 5,500 3.37 18,535
2016-05-23 Taglietti Marco (Chief Executive Officer) Buy 3,000 3.15 9,450
2016-05-20 Taglietti Marco (Chief Executive Officer) Buy 4,500 3.14 14,130
2016-05-19 Taglietti Marco (Chief Executive Officer) Buy 6,000 3.07 18,420
2015-11-24 Taglietti Marco (Chief Executive Officer) Buy 7,733 6.80 52,584
2015-11-23 Taglietti Marco (Chief Executive Officer) Buy 15,000 6.79 101,850
2015-09-15 Angulo Gonzalez David (Chief Medical Officer) Buy 3,000 7.00 21,000
2015-08-31 Taglietti Marco (Chief Executive Officer) Buy 25,000 7.82 195,500
2015-08-28 Taglietti Marco (Chief Executive Officer) Buy 400 7.15 2,860
2015-08-27 Taglietti Marco (Chief Executive Officer) Buy 1,867 7.07 13,199
2015-08-26 Taglietti Marco (Chief Executive Officer) Buy 25,000 6.98 174,500
2015-08-25 Taglietti Marco (Chief Executive Officer) Buy 25,000 7.16 178,875
2014-05-07 Ventech Capital Ii (10% Owner) Buy 28,000 10.00 280,000
2014-05-07 F.c.p.r. Genavent (10% Owner) Buy 10,000 10.00 100,000
2014-05-07 Fcpr Biotechnology Fund (10% Owner) Buy 50,000 10.00 500,000
2014-05-07 Nothias Jean-yves (Director) Buy 50,000 10.00 500,000
2014-05-07 Champsi Farah (10% Owner) Buy 900,000 10.00 9,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of SCYX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Scynexis Inc (symbol SCYX, CIK number 1178253) see the Securities and Exchange Commission (SEC) website.